External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ASN Kidney Week 2025

-
Coming soon
04:00 PM
Duration 120mins Houston, USA
Rapid (<20 mins) Multiplex Biomarker Panels Predict AKI-Sepsis Subphenotypes
Linzee Mabrey

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 120mins Houston, USA
Evaluation of Pathophysiology Biomarkers in Kidney Biopsies Collected in IMAgINATION, a Phase 3 Study of Sefaxersen in Patients With IgA Nephropathy
Jonathan Barratt

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 120mins Houston, USA
PK/PD Modeling to Support 70 mg Sefaxersen Dose Selection for Phase 3 (IMAgINATION) in IgA Nephropathy
Nelson Guerreiro

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
04:00 PM
Duration 120mins Houston, USA
Real-World Use of SGLT2 Inhibitors for IgA Nephropathy and Glomerulonephritis Patients Between 2021 and 2023
Vishal Duggal

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 15mins George R. Brown Convention Center
Beyond Clinical Response in the REGENCY Trial: The Impact of Obinutuzumab on Histologic Remission in Active Lupus Nephritis
Brad H. Rovin

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar